Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects

被引:56
作者
Paccani, SR
Boncristiano, M
Patrussi, L
Ulivieri, C
Wack, A
Valensin, S
Hirst, TR
Amedei, A
del Prete, G
Telford, JL
D'Elios, MM
Baldari, CT
机构
[1] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy
[2] Chiron Res Ctr, Siena, Italy
[3] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia
[4] Univ Florence, Dept Internal Med & Immunoallergol, Florence, Italy
关键词
D O I
10.1182/blood-2004-05-2051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Common variable immunodeficiency (CVID) is a primary immune disorder characterized by impaired antibody production, which is in many instances secondary to defective T-cell function (T-CVID). We have previously identified a subset of patients with T-CVID characterized by defective T-cell receptor (TCR)-dependent protein tyrosine phosphorylation. In these patients, ZAP-70 fails to be recruited to the TCR as the result of impaired CD3 zeta phosphorylation, which is, however, not dependent on defective Lck expression or activity. Here we show that neither Fyn nor CD45 is affected in these patients. On the other hand, T-CVID T cells show dramatic defects in the Vav/Rac pathway controlling F-actin dynamics. A significant deficiency in Vav protein was indeed observed; in 3 of 4 patients with T-CVID, it was associated with reduced VAV1 mRNA levels. The impairment in Vav expression correlated with defective F-actin reorganization in response to TCR/CD28 coengagement. Furthermore, TCR/CD28-dependent up-regulation of lipid rafts at the cell surface, which requires F-actin dynamics, was impaired in these patients. The actin cytoskeleton defect could be reversed by reconstitution of Vav1 expression in the patients' T cells. Results demonstrate an essential role of Vav in human T cells and strongly suggest Vav insufficiency in T-CVID.
引用
收藏
页码:626 / 634
页数:9
相关论文
共 64 条
[1]   T cell activation and the cytoskeleton [J].
Acuto, O ;
Cantrell, D .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :165-+
[2]   The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function [J].
Alexander, DR .
SEMINARS IN IMMUNOLOGY, 2000, 12 (04) :349-359
[3]  
BAGRODIA S, 1995, J BIOL CHEM, V270, P27995
[4]   The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity [J].
Billadeau, DD ;
Mackie, SM ;
Schoon, RA ;
Leibson, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :381-391
[5]  
Boncristiano M, 2000, EUR J IMMUNOL, V30, P2632, DOI 10.1002/1521-4141(200009)30:9<2632::AID-IMMU2632>3.0.CO
[6]  
2-C
[7]   The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms [J].
Boncristiano, M ;
Paccani, SR ;
Barone, S ;
Ulivieri, C ;
Patrussi, L ;
Ilver, D ;
Amedei, A ;
D'Elios, MM ;
Telford, JL ;
Baldari, CT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1887-1897
[8]   Regulatory and signaling properties of the Vav family [J].
Bustelo, XR .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1461-1477
[9]   Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line [J].
Cao, YJ ;
Janssen, EM ;
Duncan, AW ;
Altman, A ;
Billadeau, DD ;
Abraham, RT .
EMBO JOURNAL, 2002, 21 (18) :4809-4819
[10]   THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY [J].
COSO, OA ;
CHIARIELLO, M ;
YU, JC ;
TERAMOTO, H ;
CRESPO, P ;
XU, NG ;
MIKI, T ;
GUTKIND, JS .
CELL, 1995, 81 (07) :1137-1146